These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3979047)

  • 21. Domoprednate (Stermonid), a topical D-homocorticosteroid, skin atrophy and telangiectasia. A double-blind, randomized comparison with hydrocortisone butyrate, betamethasone valerate, clobetasole propionate and placebo.
    Serup J; Holm P
    Dermatologica; 1985; 170(4):189-94. PubMed ID: 3888708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect on adrenal axis function of topically applied betamethasone valerate ointment 0.1%.
    Fischer GO
    Australas J Dermatol; 1983 Apr; 24(1):26-32. PubMed ID: 6312951
    [No Abstract]   [Full Text] [Related]  

  • 23. Topical betamethasone 17-valerate is an anticorticosteroid in the rat. 1. Dermal atrophy.
    Young JM; Yoxall BE; Wagner BM
    Br J Dermatol; 1978 Dec; 99(6):655-63. PubMed ID: 737128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fatal iatrogenic Cushing's syndrome.
    Nathan AW; Rose GL
    Lancet; 1979 Jan; 1(8109):207. PubMed ID: 84219
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of a modified hydrocortisone/urea cream and betamethasone valerate cream in the treatment of dry eczema.
    Williamson DM
    J Int Med Res; 1987; 15(2):99-105. PubMed ID: 3582724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Norwegian scabies following topical steroid therapy.
    Clayton R; Farrow S
    Postgrad Med J; 1975 Sep; 51(599):657-9. PubMed ID: 1197167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of topical steroid application on natural killer cell activity.
    Lesko MJ; Lever RS; Mackie RM; Parrott DM
    Clin Exp Allergy; 1989 Nov; 19(6):633-6. PubMed ID: 2598103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Valisone aerosol spray contraindicated in mucous membranes.
    Beckman BI
    J Am Acad Dermatol; 1981 Feb; 4(2):233. PubMed ID: 7217392
    [No Abstract]   [Full Text] [Related]  

  • 29. The response of psoriasis to betamethasone valerate and clobetasol propionate. A 6-month controlled study.
    Corbett MF
    Br J Dermatol; 1976 Mar; 94 suppl 12():89-93. PubMed ID: 773414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparative double-blind study of a 0.1% hydrocortisone-17-butyrate cream (Locoid) and a 0.1% betamethasone-17-valerate cream (Betnovate) in patients with noninfected eczema].
    von Fischer F
    Ther Umsch; 1984 Jun; 41(6):429-32. PubMed ID: 6379975
    [No Abstract]   [Full Text] [Related]  

  • 31. A case of contact dermatitis due to betamethasone valerate--with a review of Japanese articles.
    Nakajima H; Mohri S; Nagai R
    J Dermatol; 1986 Dec; 13(6):467-70. PubMed ID: 3549824
    [No Abstract]   [Full Text] [Related]  

  • 32. Facial telangiectasia associated with long-term application of a topical corticosteroid to the scalp.
    Hogan DJ; Rooney ME
    J Am Acad Dermatol; 1989 Jun; 20(6):1129-30. PubMed ID: 2754065
    [No Abstract]   [Full Text] [Related]  

  • 33. Contact allergy to hydrocortisone and systemic contact dermatitis from prednisolone with tolerance of betamethasone.
    Isaksson M; Persson LM
    Am J Contact Dermat; 1998 Jun; 9(2):136-8. PubMed ID: 9601904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cushing's syndrome induced by topical steroids used for the treatment of non-bullous ichthyosiform erythroderma.
    Borzyskowski M; Grant DB; Wells RS
    Clin Exp Dermatol; 1976 Dec; 1(4):337-42. PubMed ID: 793745
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of corticosteroids on the growth and metabolism of fibroblasts cultured from human skin.
    Priestley GC
    Br J Dermatol; 1978 Sep; 99(3):253-61. PubMed ID: 81679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contact allergy to hydrocortisone 17-butyrate.
    Brandao FM; Camarasa FM
    Contact Dermatitis; 1979 Dec; 5(6):354-6. PubMed ID: 160854
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolism and degradation of betamethasone 17-valerate in homogenized living skin equivalent.
    Kubota K; Ademola J; Maibach HI
    Dermatology; 1994; 188(1):13-7. PubMed ID: 8305748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma cortisol levels in normal volunteers receiving either betamethasone valerate or desoximetasone by topical application.
    Bromley PA; Müller FO; Malan J; Torres J; Vanderbeke O
    S Afr Med J; 1978 Aug; 54(6):239-41. PubMed ID: 362568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topical betamethasone 17-valerate is an anticorticosteroid in the rat. 2. Anti-inflammatory and anti-lymphocyte activities.
    Young JM; Wagner BM; Fisk RA
    Br J Dermatol; 1978 Dec; 99(6):665-73. PubMed ID: 737129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New experimental approach to measure the skin-reflected light. Application to cutaneous erythema and blanching.
    Lévêque JL; Poelman MC; Legall F; de Rigal J
    Dermatologica; 1985; 170(1):12-6. PubMed ID: 3972145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.